Clinical Trial Liability: Attorneys And Consultants Offer Tips On Reducing Risk
As the number of clinical trials proliferate, so too do the situations that can lead to litigation
You may also be interested in...
IoM Report On Postmarketing Study Ethics Could Drive Broad Overhaul Of Informed Consent
Released in advance of Avandia advisory committee meeting, Institute of Medicine report provides a "conceptual framework" for deciding whether safety studies such as TIDE are ethical.
Foreign Trials, U.S. Liability: Pfizer Dealt Setback As Solicitor General Asks Supreme Court Not To Review Nigerians' Trovan Suit
If the Supreme Court lets appeals court decision stand, pharmaceutical firms could find themselves facing more litigation regarding clinical trials conducted overseas.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011